Health Care • Biotechnology: Biological Products (No Diagnostic Substances)
$27.73 ▲ +2.68
(+10.70%)
MKT CAP: $1.44B • VOL: 173.2K
52W L $24 52W H $30
LYCA CHAT <GO> // SEC 10-K & XBRL FORENSIC RAGLycia Therapeutics Inc. • CIK 0001806540
EDGAR XBRL + ITEM 1A/7FREE QUERIES: 2/2
INSTITUTIONAL AUDIT PROMPTS [CLICK TO EXECUTE]STRUCTURED CITATION ENGINE
[READY // SEC EDGAR & XBRL VECTOR WORKSTATION]
Select an audit prompt above or enter any fundamental, 10-K Risk Factor (Item 1A), MD&A (Item 7), free cash flow conversion, or FRED macro-correlation query on LYCA. Every response cites verified XBRL line items and SEC filing sections.